Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming
The nation鈥檚 top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
Vaccines
741 - 760 of 827 Results
-
-
Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims
Donald Trump accepted his party's nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.
-
COVID + Influenza: This Is a Good Year to Get a Flu Shot, Experts Advise
A robust sign-up for flu shots could help head off a nightmare scenario in the coming winter of hospitals stuffed with both COVID-19 patients and those suffering from severe effects of influenza. Plus, no one knows how flu and COVID might interact if a patient got both.
By Julie Appleby and Michelle Andrews -
LA Hospital Seeks Vaccine Trial Participants Among Its Own High-Risk Patients
Harbor-UCLA Medical Center serves patients who are especially vulnerable to the coronavirus: They are essential workers, have chronic diseases and are members of underrepresented racial and ethnic groups. When the safety-net hospital kicks off enrollment for its COVID-19 vaccine trial Wednesday, it will look to those patients to participate.
By Arthur Allen -
They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma
Advocates of cheap and widely available vaccines thought the pandemic might change business as usual. They were wrong.
By Jay Hancock -
Trust, Fear and Solidarity Will Determine the Success of a COVID Vaccine
Polio terrified Americans, and in 1955, when Jonas Salk鈥檚 vaccine became available, they snapped it up like candy. Sixty-five years later, COVID is the latest dread virus, but many undercurrents could inhibit its acceptance.
By Arthur Allen -
With COVID Vaccine Trial, Rural Oregon Clinic Steps Onto World Stage
A small allergy clinic in Medford, Oregon, might seem an unlikely place to recruit hundreds of volunteers to test the Moderna vaccine against COVID-19. But its steward has a record of leading hundreds of clinical trials.
-
Test Sites Quickly Attract Thousands for COVID-19 Vaccine Study
People have flooded U.S. testing sites with requests to participate in the pivotal, late-stage clinical trials of the first two COVID-19 vaccine candidates.
By Phil Galewitz and JoNel Aleccia -
America鈥檚 Obesity Epidemic Threatens Effectiveness of Any COVID Vaccine
Vaccines engineered to protect the public from influenza, hepatitis B, tetanus and rabies are less effective for obese people, leaving them more vulnerable to serious illness. As scientists race to develop a COVID-19 vaccine, experts say obesity could prove an impediment 鈥 a sobering prospect for a nation in which nearly half of all adults are obese.
By Sarah Varney -
Fauci Unfazed as Scientists Rely on Unproven Methods to Create COVID Vaccines
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?
By Liz Szabo -
KHN鈥檚 鈥榃hat The Health?鈥: Republicans in COVID Disarray
President Donald Trump鈥檚 sobering view of COVID-19 didn鈥檛 last long 鈥 this week, he was back to pushing hydroxychloroquine, a drug that has been shown not to work in treating the virus. Meanwhile, Republicans on Capitol Hill are still scrambling to agree among themselves and with the White House on the next coronavirus relief bill, as both a moratorium on evictions and extra unemployment payments expire. And the debate over drug prices, which was going to be one of the biggest health issues of this election year, makes a brief appearance. Alice Miranda Ollstein of Politico, Mary Ellen McIntire of CQ Roll Call and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss this and more. Also, Rovner interviews KHN鈥檚 Markian Hawryluk, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 story about a surprise bill from a surprise surgical assistant.
-
Public Health Experts Fear a Hasty FDA Signoff on Vaccine
The FDA must approve any coronavirus vaccine before it鈥檚 widely distributed, but political pressure could cloud the decision.
By Arthur Allen -
A Coronavirus Vaccine: Where Does It Stand?
Under ordinary circumstances, these phases of vaccine development can take years to complete. But now, during the age of coronavirus, the timeline is being shortened. Here's an inventory of where things stand.
-
Shingles Vaccination Rate Soars But Leaves Many Behind
A federal study finds 35% of people 60 and older were vaccinated for shingles by 2018, up from 7% in 2008, but low-income people and those who are Black or Hispanic are far less likely to get vaccinated.
-
Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
-
Must-Reads Of The Week
Easy-breezy guest writer Rachel Bluth fills you in on a healthy dose of news from this past week.
By Rachel Bluth -
KHN鈥檚 鈥榃hat the Health?鈥: SCOTUS, Trump Collide Over Transgender Rights
The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN鈥檚 Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
-
Must-Reads Of The Week
KHN senior correspondent Jordan Rau spins through this week鈥檚 essential health care news.
By Jordan Rau -
Must-Reads Of The Week
KHN executive editor Damon Darlin wades through mounds of health care policy stories 鈥 so you don鈥檛 have to.
By Damon Darlin -
KHN鈥檚 鈥榃hat The Health?鈥: When It Comes To COVID-19, States Are On Their Own
Just about every state is lifting some coronavirus-related restrictions, but it鈥檚 unclear how things are really going, considering data on the spread of the virus lags and may not be reliable. Meanwhile, the federal government continues to throw more responsibility for dealing with the pandemic to state and local governments. Margot Sanger-Katz of The New York Times, Kimberly Leonard of Business Insider and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss this and more.